Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guizhi Mixture (Guizhi Heji) is a Traditional Chinese Medicine (TCM) oral liquid formulation developed and manufactured by Chongqing Sainuo Biological Pharmaceutical. It is derived from the classic 'Guizhi Tang' formula, a cornerstone of TCM for treating exterior syndromes. The mixture is composed of five primary herbal ingredients: *Cinnamomi Ramulus* (Guizhi), *Paeoniae Radix Alba* (Shaoyao), *Zingiberis Rhizoma Recens* (Shengjiang), *Jujubae Fructus* (Dazao), and *Glycyrrhizae Radix et Rhizoma* (Gancao). Indicated for the common cold and viral colds, it is specifically used for patients presenting with 'wind-cold' symptoms such as fever, headache, sweating, and aversion to wind. The therapeutic effect is achieved through immune modulation and anti-inflammatory mechanisms, which help regulate the body's internal environment and support the immune response against viral pathogens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guizhi mixture.